share_log
Moomoo 24/7 ·  Mar 11 07:38
NLS Pharmaceutics Has Been Notified By The Listing Qualifications Department Of The Nasdaq Stock Market That The Company's Plan To Regain Compliance Submitted On February 23, 2024 Has Been Approved
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment